Solara Active Pharma Sciences Limited (SOLARA) — Capital Reinvestment Ratio

Latest as of September 2025: 0.39x

Solara Active Pharma Sciences Limited (SOLARA) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs740.70 Million) in capital expenditures (Rs286.00 Million). See Solara Active Pharma Sciences Limited net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.39x
Capex / Operating Cash Flow

Operating Cash Flow

Rs740.70 Million
INR

Capital Expenditures

Rs286.00 Million
INR

Data as of

Sep 2025
Most recent filing

Solara Active Pharma Sciences Limited Capital Reinvestment Ratio (2017–2025)

This chart tracks Solara Active Pharma Sciences Limited's Capital Reinvestment Ratio across 8 annual periods. Check SOLARA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Solara Active Pharma Sciences Limited (2017–2025)

Year-by-year Capital Reinvestment Ratio for Solara Active Pharma Sciences Limited from 2017 to 2025. For live market cap and broader valuation context, see SOLARA market cap.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 0.19x Rs2.13 Billion Rs399.40 Million ▼ -50.2%
2024 0.38x Rs1.09 Billion Rs410.60 Million ▼ -47.1%
2023 0.71x Rs1.56 Billion Rs1.11 Billion ▼ -36.5%
2021 1.12x Rs1.55 Billion Rs1.74 Billion ▲ +1.9%
2020 1.10x Rs2.44 Billion Rs2.69 Billion ▲ +235.0%
2019 0.33x Rs1.60 Billion Rs525.43 Million ▼ -53.4%
2018 0.71x Rs492.23 Million Rs347.36 Million ▲ +0.0%
2017 0.71x Rs492.23 Million Rs347.36 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow